CAHS Fellowships for Feldman & Hack

Drs. Ross Feldman and Thomas Hack were inducted as Fellows into the Canadian Academy of Health Sciences (CAHS) at an induction ceremony held in Ottawa last night.

Induction
into the CAHS as a Fellow is considered one of the highest honours within Canada’s
academic community. Fellows are chosen by their peers
based on their demonstrated leadership, creativity, distinctive competencies
and commitment to advancing academic health sciences.

“It is no surprise to me that two individuals from our institution were selected for this distinction. The exceptional achievements of both Feldman and Hack are a source of great pride here at St. Boniface,” said Dr. Grant Pierce, Executive Director of Research, St. Boniface Hospital and Distinguished Professor at the U of M.

“These outstanding clinician-scientists deserve this prestigious honour for their decades of research concerned with improving the lives and outcomes for countless patients,” says Digvir Jayas, vice-president (research and international) and Distinguished Professor at the U of M.

“It is humbling to be bestowed a Fellow in the CAHS,” said Dr. Hack.  “My research mission has all always been that of improving the health experience of individuals coping with cancer.  It is heart-warming to know that, because of my research, cancer centres and health agencies around the globe are now providing patients with opportunities to record pivotal conversations with their health providers for playback later. Advances in technology allow us to, finally and easily, bring the doctor home to the kitchen table.”

Ross Feldman

“The CAHS is a community that includes so many Canadian biomedical scholars whom I respect and emulate. I am so very grateful to now be included in that community and especially the opportunity to be there alongside those scientists and academics I so much appreciate working beside at the U of M and the St. Boniface Hospital Albrechtsen Research Centre”, said Dr. Ross Feldman.

“The CAHS is a community that includes so many Canadian biomedical scholars whom I respect and emulate. I am so very grateful to now be included in that community and especially the opportunity to be there alongside those scientists and academics I so much appreciate working beside at the U of M and the St. Boniface Hospital Albrechtsen Research Centre”, said Dr. Ross Feldman.

As a research
scientist in the Rady Faculty of Health Sciences and at St. Boniface Hospital Albrechtsen
Research Centre, Dr. Feldman’s research has provided major contributions to our
understanding of how to prevent and control of hypertension, particularly in
women. Heart disease in women remains underappreciated, underdiagnosed and
undertreated and Dr. Feldman has dedicated his career to rectifying these
shortcomings. 

Dr. Feldman was the first Chair of the Canadian Hypertension Education Program. As well, he served as the founding President of Hypertension Canada, now the second-largest cardiovascular disease not-for-profit agency in Canada. He is the author of more than 200 original manuscripts, reviews and book chapters. His clinical research focuses on the development of innovative strategies to improve blood pressure control. His fundamental research focuses on the elucidation of novel cell signalling mechanisms of vascular regulation/dysregulation linked to the development of hypertension and atherosclerosis.

Thomas Hack

Dr. Thomas Hack has made significant progress in our
understanding of the psychological issues facing cancer patients and the
end-of-life challenges that some will encounter. The professor of nursing in
the Rady Faculty of Health Sciences who is also a clinical psychologist with
CancerCare Manitoba, and a research scientist at St. Boniface Hospital
Albrechtsen Research Centre, has published
impactful research that has delved into difficult topics of compassion,
distress, depression and dignity, as well as therapeutic strategies to aid
cancer patients. He is only the second College of Nursing faculty member to be
inducted as a Fellow of the CAHS.

He was the principal
investigator of
an international
research team that explored communication between patients and health
professionals in the context of cancer, paying particular attention to the
effectiveness of using consultation recordings of primary treatment
consultations to enhance the well-being of persons diagnosed with cancer. He
also studies aspects of coping and adjustment to cancer. His work has earned
him numerous awards, including being named, in 2000, the first recipient of the
Dorothy J. Lamont Research Scientist award from the National Cancer Institute
of Canada and the Canadian Institutes of Health Research. In 2002, he received
the Queen’s Golden Jubilee Medal in recognition of his contributions to those
affected by cancer, and in 2006 and 2014 he received the University of Manitoba
Merit Award for research accomplishment. This month, Dr. Hack also received the
Lifetime Achievement Award from the Canadian Association of Psychosocial
Oncology.